Tandem Diabetes Care (TNDM) Accumulated Expenses (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Accumulated Expenses data on file, last reported at $55.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 10.4% year-over-year to $55.7 million; the trailing twelve-month figure through Mar 2026 stood at $55.7 million (up 10.4% YoY), and the FY2025 full-year result was $70.4 million, up 287.5% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $55.7 million, down from $70.4 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $70.4 million in Q4 2025 and bottomed at $12.3 million in Q3 2024.
• The 5-year median for Accumulated Expenses is $38.7 million (2022), against an average of $36.3 million.
• The widest annual swing landed in 2022, when Accumulated Expenses soared 656.39%; it then plunged 70.66% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $38.7 million in 2022, then tumbled by 67.1% to $12.7 million in 2023, then jumped by 42.78% to $18.2 million in 2024, then soared by 287.5% to $70.4 million in 2025, then declined by 20.9% to $55.7 million in 2026.
• The last three Accumulated Expenses figures came in at $55.7 million (Q1 2026), $70.4 million (Q4 2025), and $12.5 million (Q3 2025), per Business Quant data.

Peer Comparison